James Church

Prof. James Church


Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
DRDouglas K Rex
Douglas K Rex
DADennis J Ahnen
Dennis J Ahnen
JBJohn A Baron
John A Baron
KBKenneth P Batts
Kenneth P Batts
CBCarol A Burke
Carol A Burke
JCJames Church
James Church
Clinical management of serrated colorectal lesions based on current evidence and expert opinion regarding definitions, classification, and significance of serrated lesions. A consensus conference was held over 2 days reviewing the topic of serrated lesions from the perspectives of histology, molecular biology, epidemiology, clinical aspects, and serrated polyposis. Serrated lesions should be classified pathologically according to the World Health Organization criteria as hyperplastic polyp, sessile serrated adenoma/polyp (SSA/P) with or without cytological dysplasia, or traditional serrated adenoma (TSA). SSA/P and TSA are premalignant lesions, but SSA/P is the principal serrated precursor of CRCs. Serrated lesions have a distinct endoscopic appearance, and several lines of evidence suggest that on average they are more difficult to detect than conventional adenomatous polyps. Effective colonoscopy requires an endoscopist trained in the endoscopic appearance of serrated lesions. We recommend that all serrated lesions proximal to the sigmoid colon and all serrated lesions in the rectosigmoid >5 mm in size, be completely removed. Recommendations are made for post-polypectomy surveillance of serrated lesions and for surveillance of serrated polyposis patients and their relatives....

1 February 2005 in Annals of Surgery
Verified
Journal Article
Closed access
PTParis P. Md Tekkis
Paris P. Md Tekkis
VFVictor W. Mb Fazio
Victor W. Mb Fazio
ILIan C. Mbbs Lavery
Ian C. Mbbs Lavery
FRFeza H. Remzi
Feza H. Remzi
ASAntony J. Senagore
Antony J. Senagore
JCJames Church
James Church
Summary Background Data: We define the learning curve required to attain satisfactory training in ileal pouch–anal anastomosis (IPAA) and identify possible differences in the learning curve for stapled and hand-sewn IPAA surgery. Various studies have addressed the differences in failure rate between stapled and hand-sewn IPAA, but there is no literature that evaluates the differences in attaining satisfactory training in each of these techniques. Methods: Data were collected from 1965 patients undergoing IPAA surgery by 12 surgeons in a single center between 1983 and 2001. Using ileoanal pouch failure as the primary end point, a parametric survival model was used to adjust for case mix (patient comorbidity, preoperative diagnosis, manometric findings, and prior anal pathology). A risk-adjusted cumulative sum (CUSUM) model was used for monitoring outcomes in IPAA surgery. Results: The 5-year ileal pouch survival was 95.6% (median patient follow-up of 4.2 years; range 0–19 years). Fifty percent of trainee staff demonstrated a learning curve in IPAA surgery. Having adjusted for case mix, trainee staff undertaking stapled IPAA surgery showed an improvement in the pouch failure rate following an initial training period of 23 cases versus 40 cases for senior staff. The learning curve for hand-sewn IPAA surgery was quantified only for senior staff who attained adequate results following an initial period of 31 procedures. Conclusions: The CUSUM method was a useful tool for objectively measuring performance during the learning phase of IPAA surgery. With adequate training, supervision, and monitoring, the learning curve in IPAA surgery may be reduced even further.

1 June 2008 in Diseases of the Colon & Rectum
Verified
Journal Article
Closed access
JCJames Church
James Church
CLCraig Lynch
Craig Lynch
PNPaul Neary
Paul Neary
LLLisa LaGuardia
Lisa LaGuardia
EEElodie Elayi
Elodie Elayi
Intra-abdominal desmoid tumors associated with familial adenomatous polyposis are heterogeneous. A recent staging system categorizes desmoids according to size, symptoms, and complications. We applied the staging system to determine whether it separates patients into clinically significant groups. The staging system was applied to 101 patients with familial adenomatous polyposis. There were 21 patients with Stage I tumors, 36 with Stage II, 26 with Stage III, and 18 with Stage IV. Twelve patients with Stage I and five with Stage II tumors needed no treatment. Eight patients with Stage I disease received medical treatment, as did 26 with Stage II, 16 with Stage III, and 15 with Stage IV. Six Stage I tumors had surgery, as did 20 Stage II, 12 Stage III, and 13 Stage IV. Chemotherapy was given to 1 Stage II tumor, 7 Stage III, and 5 Stage IV. No patient with Stages I or II disease died. Four Stage III patients (15 percent) and 8 Stage IV patients (44 percent) died from desmoids. Finally 89 percent with Stage I, 65 percent with Stage II, 59 percent with Stage III, and 50 percent with Stage IV disease were asymptomatic; 81 percent of Stage I desmoids, 78 percent of Stage II, 42 percent of Stage III, and 28 percent of Stage IV were stable or disappeared. Desmoid staging identifies tumors by prognosis and its use for designing prospective treatment studies is reasonable.

24 November 2003 in Anz Journal of Surgery
Verified
Journal Article
Closed access
PDF file
JCJames Church
James Church

11 September 2012 in Colorectal Disease
Verified
Journal Article
Closed access
PDF file
GEG. El‐Gazzaz
G. El‐Gazzaz
THT. Hull
T. Hull
JCJames Church
James Church

12 November 2014 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
EAE. Aytac
E. Aytac
BSB. Sulu
B. Sulu
BHB. Heald
B. Heald
MOM. O'Malley
M. O'Malley
LLL. LaGuardia
L. LaGuardia
JCJames Church
James Church